Emad Abu-Assi
Overview
Explore the profile of Emad Abu-Assi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
1144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gragnano F, van Klaveren D, Heg D, Raber L, Krucoff M, Raposeiras-Roubin S, et al.
Circulation
. 2024 Oct;
151(6):343-355.
PMID: 39462482
Background: Accurate bleeding risk stratification after percutaneous coronary intervention is important for treatment individualization. However, there is still an unmet need for a more precise and standardized identification of patients...
2.
Raposeiras-Roubin S, Abu-Assi E, Perez Rivera J, Jorge Perez P, Ayesta Lopez A, Viana Tejedor A, et al.
Rev Esp Cardiol (Engl Ed)
. 2024 Jul;
78(1):56-63.
PMID: 39059729
Introduction And Objectives: Only about 1 out of every 3 patients with acute myocardial infarction (AMI) achieve low-density lipoprotein cholesterol (LDL-C) values <55mg/dL in the first year. The present study...
3.
Parada Barcia J, Raposeiras Roubin S, Fernandez D, Garcia A, Otero C, Gonzalez Bermudez I, et al.
Clin Cardiol
. 2024 Apr;
47(5):e24257.
PMID: 38664980
Background: Rate control is the most commonly employed first-line management strategy for atrial fibrillation (AF) in patients with chronic kidney disease (CKD). Principal agents used to control heart rate (HR)...
4.
Ledo Pineiro A, Abu-Assi E, Gonzalez Bermudez I, Noriega Caro V, Iniguez-Romo A, Raposeiras-Roubin S
Int J Cardiol
. 2024 Apr;
407:132086.
PMID: 38648915
Background: Diabetes mellitus (DM) increases the probability of presenting atrial fibrillation (AF) and it is a predictor of its ischemic stroke. There is limited information of the association between glycated...
5.
Abu-Assi E, Lizancos Castro A, Cespon-Fernandez M, Gonzalez-Bermudez I, Raposeiras Roubin S
Int J Cardiol
. 2024 Apr;
407:132018.
PMID: 38579940
Background: Recently, the direct oral anticoagulant (DOAC) score was developed and better predicted major bleeding in DOAC-treated patients with atrial fibrillation (AF) than HASBLED did. Little is known on the...
6.
Gonzalez-Fernandez D, Raposeiras-Roubin S, Gonzalez-Garcia A, Iglesias-Otero C, Iniguez-Romo A, Abu-Assi E
Rev Esp Cardiol (Engl Ed)
. 2023 Dec;
77(5):429-430.
PMID: 38104927
No abstract available.
7.
Elia E, Bruno F, Crimi G, Wanha W, Leonardi S, Mauro M, et al.
Int J Cardiol
. 2023 Dec;
397:131622.
PMID: 38061607
Background: Impact of gender on heart remodeling after acute coronary syndrome (ACS) and consequently on development of heart failure (HF) remains to be elucidated. Methods: CORALYS is a multicenter, retrospective,...
8.
Raposeiras-Roubin S, Parada Barcia J, Lizancos Castro A, Noriega Caro V, Ledo Pineiro A, Gonzalez Bermudez I, et al.
Clin Res Cardiol
. 2023 Nov;
113(2):313-323.
PMID: 38010520
Background And Aims: Liver diseases play an important role in the development and progression of atrial fibrillation (AF). The Fibrosis-4 (FIB-4) index is a non-invasive score recommended for detecting liver...
9.
Dominguez-Erquicia P, Raposeiras-Roubin S, Abu-Assi E, Lizancos-Castro A, Parada-Barcia J, Gonzalez-Garcia A, et al.
J Geriatr Cardiol
. 2023 Oct;
20(9):684-692.
PMID: 37840634
Background: The predictive value of bleeding risk scores for atrial fibrillation in older patients is not as well known. The goal of this study was to evaluate the predictive value...
10.
Bruno F, Marengo G, De Filippo O, Wanha W, Leonardi S, Raposeiras Roubin S, et al.
J Am Heart Assoc
. 2023 Jul;
12(15):e028475.
PMID: 37489724
Background The impact of complete revascularization (CR) on the development of heart failure (HF) in patients with acute coronary syndrome and multivessel coronary artery disease undergoing percutaneous coronary intervention remains...